Migden, M., Lear, J., Squittieri, N., Liu, L., Guminski, A. and Dummer, R. 2020. Duration of Response and Progression-Free Survival with Sonidegib 200 Mg Once Daily Until Disease Progression or Start of New Antineoplastic Therapy in Patients with Locally Advanced Basal Cell Carcinoma: Results of the 42-Month, Randomized, Double-Blind. SKIN The Journal of Cutaneous Medicine. 4, 5 (Sep. 2020), s68. DOI:https://doi.org/10.25251/skin.4.supp.67.